Market Overview
The Intermittent Catheter Market is expected to grow at a CAGR of 4.1% during the forecast period 2024-2031
An Intermittent Catheter is used in patients who are unable to do so normally to drain urine from the bladder. These catheters are meant to be used for a brief period. These are indicated for conditions like urinary leakage, incontinence, and other problems with the bladder. Neurogenic bladder diseases like spinal cord injury, multiple sclerosis, or spina bifida, as well as non-neurogenic bladder diseases, may cause urinary incontinence. The periodic catheter is placed into the urethra, and urine is gathered into the collection bag with the help of the catheter hose. A catheter should be removed after emptying the bladder. The growth of the global market for intermittent catheters is projected to rely on popularity due to a lower risk of CAUTI (catheter-acquired urinary tract infection) and the advent of more effective, less invasive, and newer catheters.
Market Scope
| Metrics | Details |
| Market CAGR | 4.1% |
| Segments Covered | By Type, By Indication, By End-User, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
For more insights - Request Free Sample
Market Dynamics
The rise in the prevalence of urinary incontinence drives the market growth
The unintentional leakage of urine is urinary incontinence. The urinary sphincter's power is either lost or diminished. It can arise due to stress factors such as coughing during and after gestation and is more frequent in conditions such as obesity. According to the American Urology Association report, a quarter to a third of men and women in the U.S. suffer from urinary incontinence. About 33 million have overactive bladder (OAB), representing symptoms of urgency, frequency, and with or without urge incontinence. OAB is a type of urinary incontinence, also called "urgency" incontinence. OAB affects more than 30% of men and 40% of women in the U.S. It affects people's lives. According to the National Library of Medicine report, women's urinary incontinence is more frequent than men's. In America, 24% to 45% of women report some degree of urinary incontinence. 7% to 37% of women ages 20 to 39 report some degree of urinary incontinence. In addition, approximately 13 million people are internationally affected by urinary incontinence in America. The chances of the disease increase with the age of human beings. Thus, the increase in the older population also accelerates the market growth.
Also, the increased demand for intermittent urinary catheters is expected to fuel the growth of the intermittent catheter industry shortly because, relative to other goods, these instruments provide greater ease of handling and low catheterization costs. Furthermore, the rise in urinary incontinence cases and the increase in the geriatric population globally are anticipated to drive market growth during the forecast period.
However, risks associated with intermittent catheters hamper the market growth. The frequent use of intermittent catheters leads to potential risks such as urinary tract infections (UTIs). Other risks include urethral stricture, urethritis, urethral bleeding, bladder stones, and genital infection. The complications associated with the use of intermittent catheters are a key factor expected to curtail the growth of the global market over the forecast period.
COVID-19 Impact on Market
The steady growth of the global intermittent catheter market.
The growth of the global demand for intermittent catheters is projected to stay stable throughout the emergence of the COVID-19 pandemic, as non-COVID-related healthcare facilities continue to run at a regular pace. The market for Intermittent Catheters is expected to stay stable in the wake of the current COVID-19 pandemic. Market participants must concentrate on solving the supply chain issues raised by the COVID-19 pandemic and designing appropriate solutions to resolve them.
Market Segmentation Analysis
The non-Coated segment is projected to be the dominant segment in the market during the forecast period.
Based on the type, the intermittent catheter market has been classified into non-coated, coated, and pre-lubricated.
Non-Coated dominated the global market in 2021, owing to the wide usage of Non coated owing to the modern Indications used in the manufacturing of Non-Coated, which reduces allergies associated with latex indications, whereas coated is expected to present considerable growth shortly. A consequence of the adoption of intermittent antimicrobial catheters helps to mitigate infections induced by catheterization.
The global intermittent catheter market is segmented based on end-user, which includes hospitals and medical research centers, and ambulatory surgery centers.
Hospitals held a significant market share in the global market during the forecast period as the majority of urinary incontinence and urinary infection cases are brought directly into the hospitals for treatment, which supports the segment growth during the forecast period. Moreover, the Medical Research Centers is expected to project a considerable CAGR during the forecast period. Increasing research and product development investments are expected to propel the segment's growth shortly.
Market Geographical Share
North America region is expected to dominate the global intermittent catheter market
Based on geography, the study analyzes the Intermittent Catheter market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
North America is dominant in the global intermittent catheter market in 2021. The U.S. is expected to represent considerable growth in North America during the forecast period. The country's well-established healthcare infrastructure and high healthcare expenditure per capita result in a huge market for Intermittent Catheters. Significant investment in R&D and advanced product development is expected to propel market growth across the region.
The intermittent catheter market for the Asia Pacific is expected to observe rapid growth over the forecast period, backed by the large population base, especially in India and China. Moreover, the rise in health care expenditure and the rapidly increasing prevalence of various urologic diseases are expected to augment the growth of the Asia Pacific intermittent catheter market.
Companies and Competitive Landscape
The intermittent catheter market is highly competitive, owing to the presence of big medical companies. The key Intermittent Catheter players contributing to the growth of the global market include. Braun Melsungen AG, ConvaTec Healthcare B S.à.r.l, Coloplast Ltd.., Cook Medical., Teleflex Incorporated., Medline Industries Inc., Medtronic, C. R. Bard Inc, Adapta Medical, Becton Dickson Company, among others. The major players are adopting new Type launch and expansion strategies for global growth in the Intermittent Catheter market. In March 2022, Convatec Group, global medical products and technologies company completed the acquisition of Triad Life Sciences Inc. This acquisition focused on the Focus-Innovate-Simplify-Build-Execute strategy and helped to strengthen Convatec’s AWC position in the US (Focus) and to secure access to a complementary and innovative technology platform (Innovation) that enhances advanced wound management and patient outcomes. In June 2022, Teleflex, a leading global provider of medical technologies, launched a new Arrow Pressure Injectable Midline Catheter in Australia and New Zealand. It enhances the Midline portfolio to meet the expanded needs of clinicians and is designed to improve patient safety. This new 20 cm Arrow Pressure Injectable Midline with brightly colored yellow hubs and labeling help clinicians overcome catheter identification confusion, which can lead to infusion mistakes that can harm patients. It is available in 1-lumen and 2-lumen configurations. In February 2022, Teleflex, a leading global provider of medical technologies, received FDA approval for Expanded Indication for specialty catheter and coronary guidewire use in crossing chronic total occlusion percutaneous coronary interventions (CTO PCI) Procedures. In February 2021, Teleflex Inc. completed the acquisition of Z-Medica LLC, an industry-leading manufacturer of hemostatic products. Z-Medica focused on the sales and marketing of innovative hemorrhage control products.
The global intermittent catheter market report would provide access to approximately 61 market data tables, 53 figures, and 170 pages.
